Table III.

Subgroup-specific miRNAs, TFs and small molecule drugs.

	miRNAs	TFs	Drugs
Group 1	miR-147b, miR-1269, miR-744, miR-483-5p, miR-1207-5p	Sp1, DAND5, PSG1, PAX5, Pax-5	Efalizumab, trastuzumab
Group 2	miR-770-5p, miR-1184, miR-133a, miR-516a-3p, miR-133b	DAND5, PSG1, Sp1, aP2-α, aP2-γ	Natalizumab, trastuzumab, efalizumab, bevacizumab, etanercept
Group 3	miR-220a, miR-492, miR-626, miR-24-1a, miR-489	Sp1, DAND5, PSG1, E2F1, E2F	NA
Group 4	miR-1247, miR-940,miR-198, miR-1289, miR-214	DAND5, PSG1, Sp1, Elk-1, CREB1	NA

NA, not applicable.